Alonso Padilla, JulioCortés Serra, NúriaPinazo, Maria-JesusBottazzi, Maria ElenaAbril, MarceloBarreira, FabianaSosa-Estani, SergioHotez, Peter J.Gascón i Brustenga, Joaquim2019-09-092019-09-092019-08-061478-7210https://hdl.handle.net/2445/139559Dear Editor, We appreciate the comments on our recent review article about strategies to enhance access to diagnosis and treatment for Chagas disease patients [1,2]. We also appreciate the opportunity to respond to them, and expand the discussion on this crucial topic given that it is estimated that no more than 1% of the infected population by Trypanosoma cruzi (of ~7 million people) ultimately get access to treatment [3]. The letter comments mainly refer to two of the sections of the review article: diagnostics to detect the infection (section 2), and treatment opportunities and possibilities (section 7).4 p.application/pdfeng(c) Informa UK Limited, 2019Malaltia de ChagasAmèrica LlatinaChagas' diseaseLatin Americainfo:eu-repo/semantics/article2019-09-06info:eu-repo/semantics/openAccess